Pelvic retroperitoneal metastasis in a patient with surgical stage-1 endometrial carcinoma
Endometrium kanseri Amerika Birleşik devletlerinde yılda yaklaşık 33.000 yeni olgunun görüldüğü, en sık karşılaşılan jinekolojik kanserdir. Uluslararası Jinekoloji ve Obstetri Federasyonu (FIGO) bilgileri ve literatürden elde edilen verilere göre, evre - 1 endometrium kanserinde 5 yıl yaşam şansının yaklaşık olarak % 70 ila % 76 civarında olduğu belirtilmektedir. Retroperitoneal yayılım, rekürrens gösteren vakaların oldukça düşük bir kısmını oluşturmaktadır. Vaka takdimimizde retroperitoneal kitlesi olan ve laparotomi sonrası yapılan histo - patolojik incelemede endometrium kanseri metastazı saptanan, 66 yaşındaki kadın hastayı sunduk.
Cerrahi evre-1 endometrium kanseri olan bir hastada pelvik retroperitoneal metastaz
Carcinoma of the endometrium is the most common gynecologic malignancy, with approximately 33,000 cases diagnosed annually in the United States (1). International Federation of Gynecology and Obstetrics (FIGO) as well as collected series from the literature more commonly report a 5 - year survival for surgical stage 1 carcinoma of the endometrium in the range of 70 % to 76 %. When the sites of the recurrence analyzed, it had been found that retroperitoneal spread is so rare. We report a 66-year-old female patient with a pelvic retroperitoneal mass which revealed metastases of endometrium cancer after biopsy of the tumor by laparatomy.
___
- 1. BoringCC, Squires TS, Tong T. Cancer statistics, 1991. CA 1991 ;41:19-36
- 2. Pettersson F, Ed. Annual report on the results of treatment in gynecologic cancer. Vol 20. Stockholm: Internationa! Federation of Gynecologic and Obstetrics, 1988:78-92.
- 3. Malkasian GD Jr, Annegers JF, Fountain KS. Carcinoma of the endometrium: Stage 1. Am J Obstet Gynecol 1980; 136:872-873.
- 4. Lotocki J, Copeland LJ, DePetrillo AD, Muirhead W. Stage 1 endometrial adenocarcinoma: Treatment results in 835 patients. Am J Obstet Gynecol 1983;146:141-5
- 5. Christopherson WM, Connelly PJ, Aberhasky RC. Carcinoma of the endometrium. An analysis of prognosticators in patients with favorable subtypes and stage 1 disease. Cancer 1983;51:1705-9
- 6. Boronow RC, Morrow CP, Creasmen WT, surgical staging in endometrial cancer. Clinical-pathologic findings of a prospective study. Obstet Gynecol. 1984;63:825-32.
- 7. DiSaia PJ, Creasmen WT, Boronow RC, Blessing JA. Risk factor and recurrent patterns in stage 1 endometrial cancer. Am J obstet. Gynecol. 1985;151:1009-15
- 8. Morrow CP, Creasman WT, Homesley H, Yordan E, Park R, Bundy B. Recurrence in endometrial carcinoma as a function of extended surgical staging data. İn: Morrow CP, Smart G. Gynecologic oncology 1985:147-53
- 9. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns in endometrial cancer. A Gynecologic Oncology Group study. Cancer 1987 ; 60: 2035 - 41
- 10. Sutton GP, Geisler HE, Stehman FB, Young PCM, Kimes TM, Ehrlich CE. Features associated with survival and disease - free survival in early endometrial cancer. Am J Obstet Gynecol. 1989 ; 160: 1385 - 93
- 11. Disaia P.J.,. Creasman W.T, Boronow, Blessing J. A., Risk factors and recurrent patterns in Stage 1 endometrial cancer. Am J Obstet Gynecol 1985; 151:1009 - 15
- 12. Lurain, JR, Brenda LR, Rademaker AW, Poggensee, LE, MS, Julian Schink JC, Miller DS, Prognostic factors associated with recurrence in clinical stage 1 adenocarcinoma of the endometrium. Am J Obstet. Gynecol 1991; 78: 63 - 69
- 13. Ng A Reagan J. incidence and prognosis of endometrial carcinoma by histologic grade and extent. Obstet Gynecol 1970; 35: 437- 44
- 14. Berman ML, Ballon SC, Lagasse LD, Watring WG. Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol 1980;136: 679-88
- 15. Aalders JG, Abler V, Kolstad P. Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patients. Gynecol Oncol 1984 Jan 17 :1 85-103